ARTICLE | Company News
NovImmune hematology news
October 22, 2012 7:00 AM UTC
The NovImmune-led FIGHT HLH consortium received €6 million ($7.8 million) from the EU's Seventh Framework Program (FP7) to develop the company's NI-0501 to treat hemophagocytic lymphohistiocytosis (H...